Healthcare is still organized by disease and paid for by the transaction.
AI agents are already taking on the easiest parts of the workflow. That’s real progress, and it’s moving health systems toward becoming AI-native.
But a more efficient sick-care system is still a sick-care system.
Meanwhile, chronic multi-morbidity is becoming the defining health challenge of the next decade, in the U.S. and around the world.
Today’s health systems, providers and payers alike, weren’t built for that. It’s where AI needs to go next.
We’re forming Modelian Health to take on the hard part: health assurance. Keeping the whole person well, not managing each disease on its own.
Health systems, payers and consumers are not ready
They are stuck in decades-old episodic, disease-centered, transactional infrastructure - in the U.S. and globally
Care is organized by disease.
Paid for transactions.
But patients carry portfolios of disease.
They can't answer three simple questions in one simple view:
- How is 'the whole' patient doing?
- What do we do about it?
- How do we know it worked?
Not ready for Outcomes-Based Reimbursement (OBR)
By 2027, this gap will become a balance-sheet liability for risk-bearing organizations.
Modelian Health goes beyond filling that gap
A category-defining platform follows five years of Whole Person Care intelligence activation R&D and ConceptVines' expertise in Ontology-first Agentic AI platform
Modelian Health models every primary disease as a governed, licensable clinical artifact — ontology, guideline logic, scoring, biomarkers, cohort baselines, care-plan activation.
Model #1 costs $X and M months. Model #100 costs 10X less and 8X faster. Revenue per model does not decline. That gap is the company.
No incumbent - EHR, data warehouse, AI assistant, or wellness ring composes a single, per-condition whole-person health score-of-scores of individuals and their lookalike populations - and activates that intelligence in-workflows
Demand is not being manufactured: the worldwide search for “Whole Person Care” has grown roughly 5× over the past decade, concentrated in exactly Modelian Health's go-to-market geographies, as federal policy institutionalizes the term and clinicians shift to AI at the point of care.
Its anchor adjacency, Population Health Management, is forecast to grow from $85B to $281B by 2030 (22% CAGR).
The international tail is larger still: 2.5B adults with ≥2 conditions, 860M with ≥4, and 400M with ≥6 by 2030.
What clinical and business CxOs in the U.S. and China have told us:
They need it. They want it. They have nothing like it.
Raising Seed Round deployed in milestone-based tranches
BUILD
Go-To-Market
BUILD
The model factory & interoperability on ConceptVines' Arbor Platform
Go-To-Market
Go-To-Market
Go-To-Market
Convert Voice-of-Customer signal into 3 early-adopter deployments
Want to learn more?
Join us and discover what we can do for you.
The content throughout this website is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Forward-looking statements (including projections, trends, and business plans) involve risks and uncertainties, and actual results may differ materially from those expressed or implied. This site contains intellectual property of ConceptVines.
© 2026 Modelian Health LLC. All rights reserved. Other brands and names are the property of their respective owners.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.